Caldwell Sutter Capital, Inc. Psychemedics Corp Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q3 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Psychemedics Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 250 shares of PMD stock, worth $500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$500
Previous $605,000
4.46%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PMD
# of Institutions
20Shares Held
1.24MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA276KShares$552,0680.72% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny271KShares$541,7260.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA251KShares$502,5660.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA142KShares$284,2840.02% of portfolio
-
Black Rock Inc. New York, NY71KShares$142,0380.0% of portfolio
About PSYCHEMEDICS CORP
- Ticker PMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 5,626,200
- Market Cap $11.3M
- Description
- Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...